HIV Treatment Adherence Dose Determination Trial
DOSE DETERMINATION TRIAL: The Start/Persist Studies
University of Connecticut
400 participants
Sep 1, 2020
INTERVENTIONAL
Conditions
Summary
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Eligibility
Inclusion Criteria3
- Confirmed HIV positive
- Confirmed prescribed antiretroviral therapy
- Confirmed non-adherent to anti-retroviral therapy
Exclusion Criteria2
- Does not have access to a phone
- Does not have access to the internet
Interventions
Telephone-delivered counseling to focus on cognitive-behavioral skills to improve HIV treatment adherence.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04577313